[The efficacy and side effects of the preoperative administration of pingyangmycin in squamous cell carcinoma of the oro-maxillo-facial region].
F Y
FY
Zhao
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D001761:Bleomycin / Q000009:adverse effects / Q000627:therapeutic use* / Q000031:analogs & derivatives; D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D003131:Combined Modality Therapy; D005153:Facial Neoplasms / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000628:therapy*; D011292:Premedication
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin; C021771:zhengguangmycin